| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGCCACUUCCAGCAUGUAGACUGAAGUCAGGCCACGCACAGGGCUCUCC… | 1776 nt | 0.6503 | |
| GUGUUUGUGAACUGGCGAUGUGAUCGAGGGCACGGGUGCUGGGCUUCCC… | 2043 nt | 0.6417 | |
| ACCCGACCGCUGCCGGCCGCGCUCCCGCUGCUCCUGCCGGGUGAUGGAA… | 1579 nt | 0.6536 |
Predicted to enable antigen binding activity; lipopolysaccharide binding activity; and metal ion binding activity. Predicted to be involved in cell adhesion. Predicted to act upstream of or within several processes, including defense response to other organism; opsonization; and positive regulation of cytokine production. Located in extracellular exosome. Biomarker of meningioma. [provided by Alliance of Genome Resources, Apr 2025]
A study in human menstrual blood-derived stem cells (MenSCs) identified the SPON2 as a differentially-expressed gene that was down-regulated with increasing passage number [Chen et al. DOI:PMC4713568]. Separately, a multi-omics study in human sepsis patients identified the SPON2 as a potential biomarker significantly associated with 28-day mortality via Mendelian randomization analysis from a low-risk, downregulated gene list [Li et al. DOI:10.1038/s41598-025-99619-z].